<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3AAngiotensin_II_receptor_blocker%2F11%2Fen</id>
	<title>Translations:Angiotensin II receptor blocker/11/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3AAngiotensin_II_receptor_blocker%2F11%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Angiotensin_II_receptor_blocker/11/en&amp;action=history"/>
	<updated>2026-09-10T07:22:50Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Translations:Angiotensin_II_receptor_blocker/11/en&amp;diff=131243&amp;oldid=prev</id>
		<title>FuzzyBot: Importing a new version from external source</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Angiotensin_II_receptor_blocker/11/en&amp;diff=131243&amp;oldid=prev"/>
		<updated>2024-03-25T09:03:20Z</updated>

		<summary type="html">&lt;p&gt;Importing a new version from external source&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Adverse effects==&lt;br /&gt;
This class of drugs is usually well tolerated. Common [[adverse drug reaction]]s (ADRs) include: dizziness, headache, and/or [[hyperkalemia]]. Infrequent ADRs associated with therapy include: first dose [[orthostatic hypotension]], rash, diarrhea, [[dyspepsia]], abnormal liver function, muscle cramp, [[myalgia]], back pain, [[insomnia]], decreased [[hemoglobin]] levels, [[renal impairment]], [[pharyngitis]], and/or nasal congestion. A 2014 Cochrane systematic review based on randomized controlled trials reported that when comparing patients taking ACE inhibitors to patients taking ARBs, fewer ARB patients withdrew from the study due to adverse events compared to ACE inhibitor patients.&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>